These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31584506)

  • 1. Nurse practitioners and barriers to diabetic foot treatment.
    Anderson M; Arvidson C
    J Am Assoc Nurse Pract; 2020 Dec; 32(12):795-799. PubMed ID: 31584506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse Practitioner Practice and Controlled Substances in Ontario: Current Practice and Future Intent.
    Moghabghab R; Hamilton-Jones M; Jabbour R; McNabb A; Tilley E
    Nurs Leadersh (Tor Ont); 2016; 29(3):93-105. PubMed ID: 28032839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of nurse practitioner controlled drugs and substances prescribing in three Canadian provinces.
    O'Rourke T; Kirk J; Duff E; Golonka R
    J Clin Nurs; 2019 Dec; 28(23-24):4342-4356. PubMed ID: 31318988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pediatric intensive care unit nurse practitioner practice: A national survey.
    Gigli KH; Dietrich MS; Buerhaus PI; Minnick AF
    J Am Assoc Nurse Pract; 2018 Jan; 30(1):17-26. PubMed ID: 29757918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurse practitioner prescribing in Australia: A comprehensive literature review.
    Fong J; Buckley T; Cashin A; Pont L
    Aust Crit Care; 2017 Sep; 30(5):252-259. PubMed ID: 27913033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State responses to COVID-19: Potential benefits of continuing full practice authority for primary care nurse practitioners.
    Poghosyan L; Pulcini J; Chan GK; Dunphy L; Martsolf GR; Greco K; Todd BA; Brown SC; Fitzgerald M; McMenamin AL; Solari-Twadell PA
    Nurs Outlook; 2022; 70(1):28-35. PubMed ID: 34763899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scope of practice and legislation for nurse practitioners in Taiwan.
    Chiu HJ; Tsay SL; Tung HH
    J Am Assoc Nurse Pract; 2015 Sep; 27(9):497-500. PubMed ID: 25764270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Providing a complete episode of care": A survey of registered nurse and registered midwife prescribing behaviours and practices.
    Casey M; Rohde D; Higgins A; Buckley T; Cashin A; Fong J; Hughes M; McHugh A
    J Clin Nurs; 2020 Jan; 29(1-2):152-162. PubMed ID: 31610060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Direct Observation of Nurse Practitioner Care study: An overview of the NP/patient visit.
    Weyer SM; Cook ML; Riley L
    J Am Assoc Nurse Pract; 2017 Jan; 29(1):46-57. PubMed ID: 27973706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse practitioners and controlled substances prescriptive authority: improving access to care.
    Ambrose MA; Tarlier DS
    Nurs Leadersh (Tor Ont); 2013 Mar; 26(1):58-69. PubMed ID: 24863581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Supervision Waivers on Practice: A Survey of Massachusetts Nurse Practitioners During the COVID-19 Pandemic.
    O'Reilly-Jacob M; Perloff J
    Med Care; 2021 Apr; 59(4):283-287. PubMed ID: 33704102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing by nurse practitioners: Insights from a New Zealand study.
    Poot B; Zonneveld R; Nelson K; Weatherall M
    J Am Assoc Nurse Pract; 2017 Oct; 29(10):581-590. PubMed ID: 28771962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Employer resistance to state authorized prescriptive authority for NPs. Results from a pilot study.
    Mahoney DF
    Nurse Pract; 1995 Jan; 20(1):58-61. PubMed ID: 7898790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning Florida NPs to opioid prescribing.
    Craig-Rodriguez A; Gordon G; Kaplan L; Grubbs L
    Nurse Pract; 2017 Sep; 42(9):1-8. PubMed ID: 28832425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID 19: An unprecedented opportunity for nurse practitioners to reform healthcare and advocate for permanent full practice authority.
    Stucky CH; Brown WJ; Stucky MG
    Nurs Forum; 2021 Jan; 56(1):222-227. PubMed ID: 33047352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enablers and Barriers to Registered Nurses Expanding Their Scope of Practice in Australia: A Cross-Sectional Study.
    Birks M; Davis J; Smithson J; Lindsay D
    Policy Polit Nurs Pract; 2019 Aug; 20(3):145-152. PubMed ID: 31390303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pursuit of Nurse Practitioner Practice Legislation: A Case Study.
    Moore C; Kabbe A; Gibson TS; Letvak S
    Policy Polit Nurs Pract; 2020 Nov; 21(4):222-232. PubMed ID: 32910736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full practice authority--effecting change and improving access to care: the Nevada journey.
    VanBeuge SS; Walker T
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):309-13. PubMed ID: 24688001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse practitioners' recommendations for pharmacotherapy in the management of adolescent concussion.
    Graves JM; Klein TA; Panther SG; Moore M; Abshire D; Graham J
    J Am Assoc Nurse Pract; 2018 Sep; 30(9):499-510. PubMed ID: 30113534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transition of nurse practitioners to changes in prescriptive authority.
    Kaplan L; Brown MA
    J Nurs Scholarsh; 2007; 39(2):184-90. PubMed ID: 17535320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.